AR019438A1 - Compuesto derivado de piperazina, usos del mismo y metodos para su fabricacion - Google Patents

Compuesto derivado de piperazina, usos del mismo y metodos para su fabricacion

Info

Publication number
AR019438A1
AR019438A1 ARP990103573A ARP990103573A AR019438A1 AR 019438 A1 AR019438 A1 AR 019438A1 AR P990103573 A ARP990103573 A AR P990103573A AR P990103573 A ARP990103573 A AR P990103573A AR 019438 A1 AR019438 A1 AR 019438A1
Authority
AR
Argentina
Prior art keywords
substituted
och3
alkanes
piperazina
manufacture
Prior art date
Application number
ARP990103573A
Other languages
English (en)
Spanish (es)
Original Assignee
Ranbaxy Lab Ltd
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Priority claimed from US09/120,265 external-priority patent/US6083950A/en
Application filed by Ranbaxy Lab Ltd filed Critical Ranbaxy Lab Ltd
Publication of AR019438A1 publication Critical patent/AR019438A1/es

Links

Classifications

    • CCHEMISTRY; METALLURGY
    • C07ORGANIC CHEMISTRY
    • C07DHETEROCYCLIC COMPOUNDS
    • C07D207/00Heterocyclic compounds containing five-membered rings not condensed with other rings, with one nitrogen atom as the only ring hetero atom
    • C07D207/02Heterocyclic compounds containing five-membered rings not condensed with other rings, with one nitrogen atom as the only ring hetero atom with only hydrogen or carbon atoms directly attached to the ring nitrogen atom
    • C07D207/30Heterocyclic compounds containing five-membered rings not condensed with other rings, with one nitrogen atom as the only ring hetero atom with only hydrogen or carbon atoms directly attached to the ring nitrogen atom having two double bonds between ring members or between ring members and non-ring members
    • C07D207/34Heterocyclic compounds containing five-membered rings not condensed with other rings, with one nitrogen atom as the only ring hetero atom with only hydrogen or carbon atoms directly attached to the ring nitrogen atom having two double bonds between ring members or between ring members and non-ring members with hetero atoms or with carbon atoms having three bonds to hetero atoms with at the most one bond to halogen, e.g. ester or nitrile radicals, directly attached to ring carbon atoms
    • C07D207/36Oxygen or sulfur atoms
    • C07D207/402,5-Pyrrolidine-diones
    • C07D207/4042,5-Pyrrolidine-diones with only hydrogen atoms or radicals containing only hydrogen and carbon atoms directly attached to other ring carbon atoms, e.g. succinimide
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61PSPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P13/00Drugs for disorders of the urinary system
    • A61P13/08Drugs for disorders of the urinary system of the prostate
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61PSPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P15/00Drugs for genital or sexual disorders; Contraceptives
    • CCHEMISTRY; METALLURGY
    • C07ORGANIC CHEMISTRY
    • C07DHETEROCYCLIC COMPOUNDS
    • C07D207/00Heterocyclic compounds containing five-membered rings not condensed with other rings, with one nitrogen atom as the only ring hetero atom
    • C07D207/02Heterocyclic compounds containing five-membered rings not condensed with other rings, with one nitrogen atom as the only ring hetero atom with only hydrogen or carbon atoms directly attached to the ring nitrogen atom
    • C07D207/30Heterocyclic compounds containing five-membered rings not condensed with other rings, with one nitrogen atom as the only ring hetero atom with only hydrogen or carbon atoms directly attached to the ring nitrogen atom having two double bonds between ring members or between ring members and non-ring members
    • C07D207/34Heterocyclic compounds containing five-membered rings not condensed with other rings, with one nitrogen atom as the only ring hetero atom with only hydrogen or carbon atoms directly attached to the ring nitrogen atom having two double bonds between ring members or between ring members and non-ring members with hetero atoms or with carbon atoms having three bonds to hetero atoms with at the most one bond to halogen, e.g. ester or nitrile radicals, directly attached to ring carbon atoms
    • C07D207/36Oxygen or sulfur atoms
    • C07D207/402,5-Pyrrolidine-diones
    • C07D207/4042,5-Pyrrolidine-diones with only hydrogen atoms or radicals containing only hydrogen and carbon atoms directly attached to other ring carbon atoms, e.g. succinimide
    • C07D207/408Radicals containing only hydrogen and carbon atoms attached to ring carbon atoms
    • CCHEMISTRY; METALLURGY
    • C07ORGANIC CHEMISTRY
    • C07DHETEROCYCLIC COMPOUNDS
    • C07D211/00Heterocyclic compounds containing hydrogenated pyridine rings, not condensed with other rings
    • C07D211/04Heterocyclic compounds containing hydrogenated pyridine rings, not condensed with other rings with only hydrogen or carbon atoms directly attached to the ring nitrogen atom
    • C07D211/80Heterocyclic compounds containing hydrogenated pyridine rings, not condensed with other rings with only hydrogen or carbon atoms directly attached to the ring nitrogen atom having two double bonds between ring members or between ring members and non-ring members
    • C07D211/84Heterocyclic compounds containing hydrogenated pyridine rings, not condensed with other rings with only hydrogen or carbon atoms directly attached to the ring nitrogen atom having two double bonds between ring members or between ring members and non-ring members with hetero atoms or with carbon atoms having three bonds to hetero atoms, with at the most one bond to halogen directly attached to ring carbon atoms
    • C07D211/86Oxygen atoms
    • C07D211/88Oxygen atoms attached in positions 2 and 6, e.g. glutarimide
    • CCHEMISTRY; METALLURGY
    • C07ORGANIC CHEMISTRY
    • C07DHETEROCYCLIC COMPOUNDS
    • C07D401/00Heterocyclic compounds containing two or more hetero rings, having nitrogen atoms as the only ring hetero atoms, at least one ring being a six-membered ring with only one nitrogen atom
    • C07D401/02Heterocyclic compounds containing two or more hetero rings, having nitrogen atoms as the only ring hetero atoms, at least one ring being a six-membered ring with only one nitrogen atom containing two hetero rings
    • C07D401/06Heterocyclic compounds containing two or more hetero rings, having nitrogen atoms as the only ring hetero atoms, at least one ring being a six-membered ring with only one nitrogen atom containing two hetero rings linked by a carbon chain containing only aliphatic carbon atoms

Landscapes

  • Chemical & Material Sciences (AREA)
  • Organic Chemistry (AREA)
  • Health & Medical Sciences (AREA)
  • Public Health (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Veterinary Medicine (AREA)
  • Engineering & Computer Science (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • General Chemical & Material Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Animal Behavior & Ethology (AREA)
  • General Health & Medical Sciences (AREA)
  • Reproductive Health (AREA)
  • Endocrinology (AREA)
  • Urology & Nephrology (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Plural Heterocyclic Compounds (AREA)
ARP990103573A 1998-07-21 1999-07-21 Compuesto derivado de piperazina, usos del mismo y metodos para su fabricacion AR019438A1 (es)

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
US09/120,265 US6083950A (en) 1997-11-13 1998-07-21 1-(4-arylpiperazin-1-yl)-ω-[n-(α,ω-dicarboximido)]-alka nes useful as uro-selective α1-adrenoceptor blockers

Publications (1)

Publication Number Publication Date
AR019438A1 true AR019438A1 (es) 2002-02-20

Family

ID=22389214

Family Applications (1)

Application Number Title Priority Date Filing Date
ARP990103573A AR019438A1 (es) 1998-07-21 1999-07-21 Compuesto derivado de piperazina, usos del mismo y metodos para su fabricacion

Country Status (10)

Country Link
CN (1) CN1168714C (cs)
AR (1) AR019438A1 (cs)
AU (1) AU1979799A (cs)
CO (1) CO5241280A1 (cs)
CZ (1) CZ2001235A3 (cs)
ID (1) ID28198A (cs)
MY (1) MY120255A (cs)
RU (1) RU2221794C2 (cs)
WO (1) WO2000005206A1 (cs)
ZA (1) ZA200100440B (cs)

Families Citing this family (8)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
AU2002253429A1 (en) * 2002-04-08 2003-10-20 Ranbaxy Laboratories Limited ALPHA, OMEGA-DICARBOXIMIDE DERIVATIVES AS USEFUL URO-SELECTIVE Alpha1Alpha ADRENOCEPTOR BLOCKERS
US7053355B2 (en) 2003-03-18 2006-05-30 Brion Technologies, Inc. System and method for lithography process monitoring and control
WO2005037281A1 (en) * 2003-10-15 2005-04-28 Ranbaxy Laboratories Limited 1-alkylpiperazinyl-pyrrolidin-2, 5-dione derivatives as adrenergic receptor antagonist
WO2005113498A1 (en) * 2004-05-19 2005-12-01 Ranbaxy Laboratories Limited Adrenergic receptor antagonists
WO2005118591A1 (en) * 2004-05-31 2005-12-15 Ranbaxy Laboratories Limited Condensed piperidine compounds acting as adrenergic receptor antagonists useful in the treatment of prostatic hyperplasia and lower urinary symptoms
WO2006018815A1 (en) * 2004-08-16 2006-02-23 Ranbaxy Laboratories Limited Piperazine derivatives as adrenergic receptor antagonists
WO2006051374A2 (en) * 2004-11-11 2006-05-18 Ranbaxy Laboratories Limited Arylpiperazines useful as adrenergic receptor antagonists
CN103864761B (zh) * 2014-03-12 2016-01-20 天津药物研究院有限公司 一种含吡啶的哌嗪类衍生物及其制备方法和用途

Family Cites Families (7)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
BE788280A (fr) * 1971-09-04 1973-02-28 Pfizer Nouvelles 1-(3-trifluoro-methyl-phenyl)-4-((amido cyclique)- alkyl) piperazines et composition pharmaceutique les contenant
DE2727469A1 (de) * 1977-06-18 1978-12-21 Hoechst Ag Neue hexahydropyrimidine, verfahren zu ihrer herstellung und arzneimittel, die diese verbindungen enthalten
JPS57197265A (en) * 1981-05-29 1982-12-03 Eisai Co Ltd Carboxylic acid imide derivative, its preparation and medicament containing the same
US4452798A (en) * 1982-06-22 1984-06-05 Warner-Lambert Company 1-Substituted phenyl-4-alkyl hydantoin piperazine compounds as antihypertensive agents
US4675403A (en) * 1985-10-16 1987-06-23 American Home Products Corporation 3-Aminoalkyl derivatives of 5,5-disubstituted hydantoins with psychotropic activity
ES2094690B1 (es) * 1994-11-22 1997-08-01 Univ Madrid Complutense Nuevos derivados de imida-piperazinas.
DE69612698T2 (de) * 1995-06-09 2001-12-06 Hoffmann La Roche Pyrimidindion-, Pyrimidintrion-, Triazindion-Derivate als alpha-1-adrenergische Rezeptorantagonisten

Also Published As

Publication number Publication date
WO2000005206A1 (en) 2000-02-03
AU1979799A (en) 2000-02-14
ZA200100440B (en) 2002-10-04
CO5241280A1 (es) 2003-01-31
CZ2001235A3 (cs) 2001-08-15
CN1318052A (zh) 2001-10-17
RU2221794C2 (ru) 2004-01-20
ID28198A (id) 2001-05-10
CN1168714C (zh) 2004-09-29
WO2000005206A8 (en) 2000-03-16
MY120255A (en) 2005-09-30

Similar Documents

Publication Publication Date Title
PE20020504A1 (es) N-acilsulfonamidas promotoras de apoptosis
PE10290A1 (es) Procedimiento de preparacion de derivados de benzotriazol
AR046297A1 (es) Inhibidores de la dpp - iv metodos para prepararlos y composiciones farmaceuticas que los contienen como agente activo
RU2291860C3 (ru) Производные 2-оксо-1-пирролидина, способ их получения и применения
DE68906183D1 (de) 2'-desoxy-5-fluoruridinderivate.
CY1110355T1 (el) Ενεργοποιητης του ενεργοποιουμενου απο πολλαπλασιαστη υπεροξυσωματων υποδοχεα δ
CU23413B7 (es) Nuevos derivados de benzoimidazol útiles como agentes antiproliferativos
PE20011314A1 (es) DERIVADOS DE N-(4-CARBAMIMIDOIL-FENIL)-GLICINA COMO INHIBIDORES DE LA FORMACION DE FACTORES DE COAGULACION Xa IXa Y TROMBINA
CO5540385A2 (es) Derivados quirales de acido oxazol arilpropionico, su metodo de sintesis ycomposiciones farmaceuticas que los contienen
ATE362931T1 (de) 8-azabicyclo(3.2.1)oct-2en-derivate, deren herstellung und anwendung
AR043485A1 (es) Derivados del 8'-piridinil-dihidrospiro-[cicloalquil]-pirimido[1,2a]pirimidin-6-ona y 8´-pirimidinil-dihidrospiro-[cicloalquil]-pirimido[1,2a]pirimidin-6-ona substituidos
NO20050612L (no) Pyrrolidinderivater som oksytocinantagonister
AR019438A1 (es) Compuesto derivado de piperazina, usos del mismo y metodos para su fabricacion
ATE127117T1 (de) 1-aryl-1-hydroxy-1-substituierte-3-(4- substituierte-1-piperazinyl)-2-propanone und ihre verwendung bei der behandlung von blasenstörungen neurologischen ursprungs.
SE8505887L (sv) Indoler
PT1216245E (pt) Derivados sulfonil-hidrazida farmaceuticamente activos
AR021900A1 (es) Derivados del cromano, sus sales y enantiomeros, un procedimiento para su preparacion y el empleo de los mismos como productos intermedios para la sintesis de medicamentos.
AR040123A1 (es) Compuestos tiofeno, antihelminticos e insecticidas
ES2068497T3 (es) Derivados de urea, su produccion, y composiciones farmaceuticas que los contienen.
DE3769384D1 (de) N-2(dimethylamino)ethyl n.(2((2(methylthio)phenyl)(phenylmethyl))amino-2-oxo)ethyl) carbamidsaeureester und harnstoffe-herstellungsverfahren und therapeutisches mittel.
ES2124413T3 (es) Derivados de piridazinona con actividad farmaceutica.
ATE295166T1 (de) Aktivatoren der kalium-kanäle
AR013889A1 (es) Nuevos derivados del acido 4-(1-piperazinil)-benzoico, procedimiento para obtenerlos y composiciones farmaceuticas que lo contienen.
ES2155655T3 (es) Compuestos de benzotiofeno, usos y formulaciones de los mismos.
PE20010165A1 (es) Derivados de 1-trifluorometil-4-hidroxi-7-piperidinil-aminometilcromano como antagonistas de la sustancia p

Legal Events

Date Code Title Description
FA Abandonment or withdrawal